AC THERAPEUTICS LIMITED

Active London

Other business support service activities n.e.c.

135 employees website.com
Life sciences and medical technology Other business support service activities n.e.c.
A

AC THERAPEUTICS LIMITED

Other business support service activities n.e.c.

Founded 13 Dec 2016 Active London, United Kingdom 135 employees website.com
Life sciences and medical technology Other business support service activities n.e.c.
Accounts Submitted 9 Jan 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 11 Feb 2025 Next due 26 Dec 2025 6 months overdue
Net assets £79M £40M 2024 year on year
Total assets £109M £48M 2024 year on year
Total Liabilities £30M £8M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Unit 2.02 ,411-413 Oxford Street London W1C 2PE United Kingdom

Email

info@example.com

Website

www.example.com

Full company profile for AC THERAPEUTICS LIMITED (10522129), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 13 Dec 2016. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type group
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2020–2024)

Cash in Bank

£40.61M

Increased by £36.12M (+805%)

Net Assets

£79.10M

Increased by £39.53M (+100%)

Total Liabilities

£30.10M

Increased by £8.33M (+38%)

Turnover

£95.75M

Increased by £12.34M (+15%)

Employees

135

Increased by 28 (+26%)

Debt Ratio

28%

Decreased by 7 (-20%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Augustinus BaderDirectorGermanGermany6613 Dec 2016Active
Charles Antoine Monique Chantal RosierDirectorFrenchUnited Arab Emirates5213 Apr 2017Active
Veyrat, Jacques FrancisDirectorFrenchFrance633 Sept 2025Active

Shareholders

Shareholders (2)

3ys (pte. Ltd.)
50.0%
Charles Rosier
50.0%

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Augustinus Bader

German

Active
Notified 13 Dec 2016
Residence Germany
DOB August 1959
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Charles Rosier

French

Active
Notified 13 Apr 2017
Residence United Arab Emirates
DOB November 1973
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

3ys Pte Ltd

Ceased 13 Dec 2016

Ceased

Group Structure

Group Structure

AC THERAPEUTICS LIMITED Current Company
ASC CLINICS LIMITED united kingdom
ASC REGENITY LIMITED united kingdom

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
16 Feb 2026OfficersTermination of Jacques Francis Veyrat as director on 12 Feb 2026
9 Jan 2026AccountsAnnual accounts made up to 31 Dec 2024
29 Dec 2025InsolvencySolvency Statement dated 17/12/25
29 Dec 2025CapitalCapital Statement Capital Company With Date Currency Figure
29 Dec 2025ResolutionResolutions
16 Feb 2026 Officers

Termination of Jacques Francis Veyrat as director on 12 Feb 2026

9 Jan 2026 Accounts

Annual accounts made up to 31 Dec 2024

29 Dec 2025 Insolvency

Solvency Statement dated 17/12/25

29 Dec 2025 Capital

Capital Statement Capital Company With Date Currency Figure

29 Dec 2025 Resolution

Resolutions

Recent Activity

Latest Activity

Termination of Jacques Francis Veyrat as director on 12 Feb 2026

3 months ago on 16 Feb 2026

Annual accounts made up to 31 Dec 2024

4 months ago on 9 Jan 2026

Solvency Statement dated 17/12/25

5 months ago on 29 Dec 2025

Capital Statement Capital Company With Date Currency Figure

5 months ago on 29 Dec 2025

Resolutions

5 months ago on 29 Dec 2025